{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:52:32Z","timestamp":1790790752385,"version":"4.1.0"},"reference-count":154,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>The use of noninvasive biomarkers may reduce the need for biopsy and guide immunosuppression adjustments during transplantation. The scientific community in solid organ transplantation currently considers that chemokines, T- and B-cell immunophenotypes, and gene expression, among other molecular biomarkers, have great potential as diagnostic and predictive biomarkers for graft evolution; however, in clinical practice, few valid early biomarkers have emerged. This review focuses on the most relevant scientific advances in this field in the last 5 years regarding the role of 3 biomarkers: miRNAs, chemokines, and ddcf-DNA, in both adult and pediatric populations. An update was provided on the scores based on the combination of these biomarkers. The most-featured articles were identified through a literature search of the PubMed database. This review provides a comprehensive analysis of the potential clinical applications of these biomarkers in the diagnosis and prediction of graft outcomes and discusses the reasons why none have been implemented in clinical practice to date. Translating these biomarkers into routine clinical practice and combining them with pharmacogenetics and pharmacokinetic monitoring is challenging; however, it is the key to present\/future individualized immunosuppressive therapies. It is essential that they be shown to be applicable and robust in real-life patient conditions and properly evaluate their added value when combined with the standard-of-care factor monitoring for graft clinical assessment. Partnership strategies among scientists, academic institutions, consortia, including expert working groups and scientific societies, and pharmaceutical and\/or biotechnology companies should promote the development of prospective, randomized, multicenter intervention studies for adequate clinical validation of these biomarkers and their monitoring frequency, and their commercialization to make them available to transplant physicians.<\/jats:p>","DOI":"10.1097\/ftd.0000000000001276","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T15:01:02Z","timestamp":1730905262000},"page":"77-97","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["miRNAs, dd-cf-DNA, and Chemokines as Potential Noninvasive Biomarkers for the Assessment of Clinical Graft Evolution and Personalized Immunosuppression Requirement in Solid Organ Transplantation"],"prefix":"10.1097","volume":"47","author":[{"given":"Olga","family":"Mill\u00e1n","sequence":"first","affiliation":[{"name":"Biomedical Research Center in Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III (ISCII), c\/Sinesio Delgado, Madrid; and"},{"name":"Pharmacology and Toxicology, Biochemistry and Molecular Genetics, Biomedical Diagnostic Center (CDB), Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, c\/Villarroel, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Julian","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Biochemistry and Molecular Genetics, Biomedical Diagnostic Center (CDB), Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, c\/Villarroel, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Brunet","sequence":"additional","affiliation":[{"name":"Biomedical Research Center in Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III (ISCII), c\/Sinesio Delgado, Madrid; and"},{"name":"Pharmacology and Toxicology, Biochemistry and Molecular Genetics, Biomedical Diagnostic Center (CDB), Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, c\/Villarroel, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"R1-20250108","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/CS20220530","article-title":"Precision diagnostics in transplanted organs using microarray-assessed gene expression: concepts and technical methods of the Molecular Microscope Diagnostic System (MMDx)","volume":"138","author":"Madill-Thomsen","year":"2024","journal-title":"Clin Sci (Lond)."},{"key":"R2-20250108","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R3-20250108","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monit."},{"key":"R4-20250108","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/TP.0000000000003895","article-title":"Prediction of liver transplant rejection with a biologically relevant gene expression signature","volume":"106","author":"Levitsky","year":"2022","journal-title":"Transplantation."},{"key":"R5-20250108","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/FTD.0000000000000287","article-title":"Barcelona consensus on biomarker-based immunosuppressive drugs management in solid organ transplantation","volume":"38","author":"Brunet","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R6-20250108","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/lt.26272","article-title":"Monitoring of donor-derived cell-free DNA by short tandem repeats: concentration of total cell-free DNA and fragment size for acute rejection risk assessment in liver transplantation","volume":"28","author":"Fern\u00e1ndez-Gal\u00e1n","year":"2022","journal-title":"Liver Transplant."},{"key":"R7-20250108","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/ajt.15953","article-title":"Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation","volume":"20","author":"Levitsky","year":"2020","journal-title":"Am J Transplant."},{"key":"R8-20250108","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/TP.0000000000004580","article-title":"Novel noninvasive biomarkers in liver transplantation: a tool on the doorstep of clinical utilization","volume":"107","author":"Merola","year":"2023","journal-title":"Transplantation."},{"key":"R9-20250108","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1111\/ajt.15959","article-title":"Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection","volume":"20","author":"Tinel","year":"2020","journal-title":"Am J Transplant."},{"key":"R10-20250108","doi-asserted-by":"crossref","first-page":"e0220052","DOI":"10.1371\/journal.pone.0220052","article-title":"A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring","volume":"14","author":"Sigdel","year":"2019","journal-title":"PLoS One."},{"key":"R11-20250108","doi-asserted-by":"crossref","first-page":"eaba2501","DOI":"10.1126\/scitranslmed.aba2501","article-title":"A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection","volume":"12","author":"Yang","year":"2020","journal-title":"Sci Transl Med."},{"key":"R12-20250108","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis."},{"key":"R13-20250108","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ng1590","article-title":"Identification of hundreds of conserved and nonconserved human microRNAs","volume":"37","author":"Bentwich","year":"2005","journal-title":"Nat Genet."},{"key":"R14-20250108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell."},{"key":"R15-20250108","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.coph.2009.05.003","article-title":"microRNAs and the immune response","volume":"9","author":"Tsitsiou","year":"2009","journal-title":"Curr Opin Pharmacol."},{"key":"R16-20250108","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41435-024-00283-6","article-title":"The ability of microRNAs to regulate the immune response in ischemia\/reperfusion inflammatory pathways","volume":"25","author":"Artimovi\u010d","year":"2024","journal-title":"Genes Immun."},{"key":"R17-20250108","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"R18-20250108","doi-asserted-by":"crossref","first-page":"121722","DOI":"10.1016\/j.lfs.2023.121722","article-title":"Exosomes in transplantation: role in allograft rejection, diagnostic biomarker, and therapeutic potential","volume":"324","author":"Saravanan","year":"2023","journal-title":"Life Sci."},{"key":"R19-20250108","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clim.2019.04.010","article-title":"The exosome as a novel predictive\/diagnostic biomarker of rejection in the field of transplantation","volume":"203","author":"Mirzakhani","year":"2019","journal-title":"Clin Immunol."},{"key":"R20-20250108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/iji.12654","article-title":"Non-invasive molecular biomarkers for monitoring solid organ transplantation: a comprehensive overview","volume":"51","author":"Fernando","year":"2024","journal-title":"Int J Immunogenet."},{"key":"R21-20250108","doi-asserted-by":"crossref","first-page":"1190576","DOI":"10.3389\/fimmu.2023.1190576","article-title":"Development and validation of urinary exosomal microRNA biomarkers for the diagnosis of acute rejection in kidney transplant recipients","volume":"14","author":"Seo","year":"2023","journal-title":"Front Immunol."},{"key":"R22-20250108","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40291-019-00397-y","article-title":"Identification of candidate biomarkers for transplant rejection from transcriptome data: a systematic review","volume":"23","author":"Paladini","year":"2019","journal-title":"Mol Diagn Ther."},{"key":"R23-20250108","first-page":"30","article-title":"A systematic review and meta-analysis of microRNA profiling studies in chronic kidney diseases","volume":"10","author":"Garmaa","year":"2024","journal-title":"Noncoding RNA"},{"key":"R24-20250108","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.kint.2018.06.033","article-title":"Noncoding RNAs in acute kidney injury","volume":"94","author":"Brandenburger","year":"2018","journal-title":"Kidney Int."},{"key":"R25-20250108","doi-asserted-by":"crossref","first-page":"F878","DOI":"10.1152\/ajprenal.00567.2019","article-title":"miR-214 represses mitofusin-2 to promote renal tubular apoptosis in ischemic acute kidney injury","volume":"318","author":"Yan","year":"2020","journal-title":"Am J Physiol Renal Physiol."},{"key":"R26-20250108","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1038\/srep04283","article-title":"The effect of microRNAs in the regulation of human CYP3A4: a systematic study using a mathematical model","volume":"4","author":"Wei","year":"2014","journal-title":"Sci Rep."},{"key":"R27-20250108","doi-asserted-by":"crossref","first-page":"2587104","DOI":"10.1155\/2023\/2587104","article-title":"Association of MicroRNA-146a with type 1 and 2 diabetes and their related complications","volume":"2023","author":"Ghaffari","year":"2023","journal-title":"J Diabetes Res."},{"key":"R28-20250108","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1073\/pnas.0813121106","article-title":"MicroRNA expression profiles predictive of human renal allograft status","volume":"106","author":"Anglicheau","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-20250108","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1111\/bcp.13399","article-title":"Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation","volume":"83","author":"Mill\u00e1n","year":"2017","journal-title":"Br J Clin Pharmacol."},{"key":"R30-20250108","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbadis.2016.10.027","article-title":"microRNAs in the pathophysiology of CKD-MBD: biomarkers and innovative drugs","volume":"1863","author":"Metzinger-Le Meuth","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"R31-20250108","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3390\/jcm13061600","article-title":"Plasma miR-150-5p in renal transplant recipients with acute antibody-mediated rejection","volume":"13","author":"Zepeda-Quiroz","year":"2024","journal-title":"J Clin Med."},{"key":"R32-20250108","doi-asserted-by":"crossref","first-page":"12154","DOI":"10.1111\/jcmm.15861","article-title":"A circulating exosomal microRNA panel as a novel biomarker for monitoring post-transplant renal graft function","volume":"24","author":"Chen","year":"2020","journal-title":"J Cel Mol Med"},{"key":"R33-20250108","first-page":"1759697","article-title":"Expression profiling of exosomal miRNAs derived from the peripheral blood of kidney recipients with DGF using high-throughput sequencing","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed Res Int."},{"key":"R34-20250108","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12985-022-01880-5","article-title":"Cytomegalovirus microRNAs level determination in kidney recipients post transplantation","volume":"19","author":"Afshari","year":"2022","journal-title":"Virol J."},{"key":"R35-20250108","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/lt.22438","article-title":"Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation","volume":"18","author":"Farid","year":"2012","journal-title":"Liver Transplant."},{"key":"R36-20250108","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/hep.28786","article-title":"An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection","volume":"65","author":"Shaked","year":"2017","journal-title":"Hepatology"},{"key":"R37-20250108","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fimmu.2019.00873","article-title":"Monitoring of miR-181a-5p and miR-155-5p plasmatic expression as prognostic biomarkers for acute and subclinical rejection in de novo adult liver transplant recipients","volume":"10","author":"Mill\u00e1n","year":"2019","journal-title":"Front Immunol"},{"key":"R38-20250108","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/lt.25842","article-title":"MicroRNAs 155\u20105p, 122\u20105p, and 181a\u20105p identify patients with graft dysfunction due to T cell\u2013mediated rejection after liver transplantation","volume":"26","author":"Ruiz","year":"2020","journal-title":"Liver Transplant"},{"key":"R39-20250108","doi-asserted-by":"crossref","first-page":"196882","DOI":"10.3389\/fimmu.2023.1196882","article-title":"A plasmatic score using a miRNA signature and CXCL-10 for accurate prediction and diagnosis of liver allograft rejection","volume":"14","author":"Mill\u00e1n","year":"2023","journal-title":"Front Immunol"},{"key":"R40-20250108","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/TP.0000000000003815","article-title":"Serum MicroRNA transcriptomics and acute rejection or recurrent hepatitis C virus in human liver allograft recipients: a pilot study","volume":"106","author":"Muthukumar","year":"2022","journal-title":"Transplantation"},{"key":"R41-20250108","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.3390\/ijms24043457","article-title":"Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as potential biomarkers in human liver transplantation follow-up","volume":"24","author":"Morsiani","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R42-20250108","doi-asserted-by":"crossref","first-page":"1015049","DOI":"10.3389\/fgene.2022.1015049","article-title":"Serum extracellular vesicle MicroRNAs as candidate biomarkers for acute rejection in patients subjected to liver transplant","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"R43-20250108","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/ehf2.13238","article-title":"Longitudinal profiling of circulating miRNA during cardiac allograft rejection: a proof-of-concept study","volume":"8","author":"Kennel","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R44-20250108","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/eurheartj\/ehu376","article-title":"Towards novel theranostic approaches in cardiac transplantation medicine","volume":"35","author":"Batkai","year":"2014","journal-title":"Eur Heart J"},{"key":"R45-20250108","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1093\/eurheartj\/ehu346","article-title":"MicroRNAs as non-invasive biomarkers of heart transplant rejection","volume":"35","author":"Duong Van Huyen","year":"2014","journal-title":"Eur Heart J"},{"key":"R46-20250108","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.healun.2023.07.010","article-title":"Validation of the clinical utility of microRNA as noninvasive biomarkers of cardiac allograft rejection: a prospective longitudinal multicenter study","volume":"42","author":"Coutance","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"R47-20250108","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.healun.2020.05.018","article-title":"Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation","volume":"39","author":"Constanso-Conde","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R48-20250108","first-page":"e01708432","article-title":"Association of serum MiR-142-3p and MiR-101-3p levels with acute cellular rejection after heart transplantation","volume":"12","author":"Sukma","year":"2017","journal-title":"PLoS One"},{"key":"R49-20250108","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.healun.2015.06.008","article-title":"Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy","volume":"34","author":"Singh","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R50-20250108","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/TP.0000000000001477","article-title":"MicroRNA 628-5p as a novel biomarker for cardiac allograft vasculopathy","volume":"101","author":"Neumann","year":"2017","journal-title":"Transplantation"},{"key":"R51-20250108","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.healun.2022.06.019","article-title":"Circulating microRNAs in cellular and antibody-mediated heart transplant rejection","volume":"41","author":"Shah","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R52-20250108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.healun.2017.07.012","article-title":"Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection","volume":"37","author":"Kennel","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R53-20250108","doi-asserted-by":"crossref","first-page":"E547","DOI":"10.1097\/TXD.0000000000000994","article-title":"Bronchoalveolar lavage-microRNAs are potential novel biomarkers of outcome after lung transplantation","volume":"6","author":"Palleschi","year":"2020","journal-title":"Transpl Direct"},{"key":"R54-20250108","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/ajt.13185","article-title":"Dysregulated MicroRNA expression and chronic lung allograft rejection in recipients with antibodies to donor HLA","volume":"15","author":"Xu","year":"2015","journal-title":"Am J Transplant"},{"key":"R55-20250108","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3390\/ijms25031911","article-title":"New insights into pediatric kidney transplant rejection biomarkers: tissue, plasma and urine MicroRNAs compared to protocol biopsy histology","volume":"25","author":"Carraro","year":"2024","journal-title":"Int J Mol Sci."},{"key":"R56-20250108","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/TP.0000000000001595","article-title":"Role of circulating MicroRNAs in the immunopathogenesis of rejection after pediatric lung transplantation","volume":"101","author":"Xu","year":"2017","journal-title":"Transplantation"},{"key":"R57-20250108","doi-asserted-by":"crossref","first-page":"115389","DOI":"10.1016\/j.taap.2020.115389","article-title":"Variation in the expression of cytochrome P450-related miRNAs and transcriptional factors in human livers: correlation with cytochrome P450 gene phenotypes","volume":"412","author":"feng","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"R58-20250108","doi-asserted-by":"crossref","first-page":"113725","DOI":"10.1016\/j.bcp.2019.113725","article-title":"MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation","volume":"171","author":"Kugler","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"R59-20250108","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.1074\/jbc.M709382200","article-title":"Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4","volume":"283","author":"Takagi","year":"2008","journal-title":"J Biol Chem"},{"key":"R60-20250108","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1124\/dmd.109.027680","article-title":"MicroRNAs regulate CYP3A4 expression via direct and indirect targeting","volume":"37","author":"Pan","year":"2009","journal-title":"Drug Metab Disposition"},{"key":"R61-20250108","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/tpj.2010.28","article-title":"Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs","volume":"11","author":"Wang","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"R62-20250108","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1373\/clinchem.2005.050047","article-title":"Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus","volume":"51","author":"Kamdem","year":"2005","journal-title":"Clin Chem"},{"key":"R63-20250108","doi-asserted-by":"crossref","first-page":"105382","DOI":"10.1016\/j.phrs.2020.105382","article-title":"Multiple microRNAs regulate tacrolimus metabolism through CYP3A5","volume":"164","author":"Gu","year":"2021","journal-title":"Pharmacol Res"},{"key":"R64-20250108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.fpc.0000184953.31324.e4","article-title":"Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients","volume":"16","author":"Uesugi","year":"2006","journal-title":"Pharmacogenet Genomics."},{"key":"R65-20250108","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.3389\/ti.2023.12115","article-title":"European society of organ transplantation consensus statement on testing for non-invasive diagnosis of kidney allograft rejection","volume":"36","author":"Park","year":"2024","journal-title":"Transpl Int"},{"key":"R66-20250108","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1053\/j.ajkd.2023.07.022","article-title":"Automated urinary chemokine assays for noninvasive detection of kidney transplant rejection: a prospective cohort study","volume":"83","author":"Van Loon","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"R67-20250108","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40291-019-00397-y","article-title":"Identification of candidate biomarkers for transplant rejection from transcriptome data: a systematic review","volume":"23","author":"Paladini","year":"2019","journal-title":"Mol Diagn Ther."},{"key":"R68-20250108","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/ajt.13677","article-title":"Early low urinary CXCL9 and CXCL10 might predict immunological quiescence in clinically and histologically stable kidney recipients","volume":"16","author":"Rabant","year":"2016","journal-title":"Am J Transplant"},{"key":"R69-20250108","doi-asserted-by":"crossref","first-page":"108792","DOI":"10.1016\/j.clim.2021.108792","article-title":"Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation","volume":"229","author":"Mill\u00e1n","year":"2021","journal-title":"Clin Immunol"},{"key":"R70-20250108","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fmed.2020.00114","article-title":"Non-invasive chemokine detection: improved prediction of antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients","volume":"7","author":"M\u00fchlbacher","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"R71-20250108","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1681\/ASN.0000000000000160","article-title":"Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine","volume":"34","author":"Hirt-Minkowski","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"R72-20250108","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/TP.0000000000004393","article-title":"Modulation of monocyte response by MicroRNA-15b\/106a\/374a during antibody-mediated rejection in kidney transplantation","volume":"107","author":"Tinel","year":"2023","journal-title":"Transplantation"},{"key":"R73-20250108","doi-asserted-by":"crossref","first-page":"e15324","DOI":"10.1111\/ctr.15324","article-title":"CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions","volume":"38","author":"Gandolfini","year":"2024","journal-title":"Clin Transpl"},{"key":"R74-20250108","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/TP.0000000000001931","article-title":"Urinary CXCL10 chemokine is associated with alloimmune and virus compartment-specific renal allograft inflammation","volume":"102","author":"Ho","year":"2018","journal-title":"Transplantation"},{"key":"R75-20250108","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/tri.13584","article-title":"Longitudinal assessment of the CXCL10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication\u2014a retrospective study","volume":"33","author":"Weseslindtner","year":"2020","journal-title":"Transpl Int"},{"key":"R76-20250108","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/lt.24164","article-title":"CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation","volume":"21","author":"Raschzok","year":"2015","journal-title":"Liver Transplant"},{"key":"R77-20250108","doi-asserted-by":"crossref","first-page":"639","DOI":"10.14348\/molcells.2016.0130","article-title":"Combined detection of serum IL-10, IL-17, and CXCL10 predicts acute rejection following adult liver transplantation","volume":"39","author":"Kim","year":"2016","journal-title":"Mol Cell"},{"key":"R78-20250108","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1159\/000464114","article-title":"Alterations of serum IP-10 and TARC in patients with early acute rejection after liver transplantation","volume":"41","author":"Meng","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"R79-20250108","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/00007890-199611270-00011","article-title":"Cytokine pattern during rejection and infection after liver transplantation-improvements in postoperative monitoring?","volume":"62","author":"Platz","year":"1996","journal-title":"Transplantation"},{"key":"R80-20250108","doi-asserted-by":"crossref","first-page":"765768","DOI":"10.3389\/fphar.2021.765768","article-title":"The role of CXC chemokines in cardiovascular diseases","volume":"12","author":"Lu","year":"2022","journal-title":"Front Pharmacol."},{"key":"R81-20250108","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1161\/hc4601.098010","article-title":"Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection","volume":"104","author":"Melter","year":"2001","journal-title":"Circulation"},{"key":"R82-20250108","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/TP.0b013e3182a6ee0a","article-title":"Elevated CXCL10 (IP-10) in bronchoalveolar lavage fluid is associated with acute cellular rejection after human lung transplantation","volume":"97","author":"Husain","year":"2014","journal-title":"Transplantation"},{"key":"R83-20250108","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/ajt.14397","article-title":"The prognostic importance of bronchoalveolar lavage fluid CXCL9 during minimal acute rejection on the risk of chronic lung allograft dysfunction","volume":"18","author":"Shino","year":"2018","journal-title":"Am J Transplant"},{"key":"R84-20250108","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/ajt.17108","article-title":"Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction","volume":"22","author":"Shino","year":"2022","journal-title":"Am J Transplant"},{"key":"R85-20250108","first-page":"29","article-title":"The impact of allograft CXCL9 during respiratory infection on the risk of chronic lung allograft dysfunction","volume":"2","author":"DerHovanessian","year":"2018","journal-title":"OBM Transpl"},{"key":"R86-20250108","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/TP.0000000000000419","article-title":"Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation","volume":"99","author":"Blydt-Hansen","year":"2015","journal-title":"Transplantation"},{"key":"R87-20250108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/petr.13908","article-title":"Biomarker implementation: evaluation of the decision-making impact of CXCL10 testing in a pediatric cohort","volume":"25","author":"Lamarche","year":"2021","journal-title":"Pediatr Transpl"},{"key":"R88-20250108","doi-asserted-by":"crossref","first-page":"e1471","DOI":"10.1111\/petr.14718","article-title":"Optimizing the approach to monitoring allograft inflammation using serial urinary CXCL10\/creatinine testing in pediatric kidney transplant recipients","volume":"28","author":"Barrett-Chan","year":"2024","journal-title":"Pediatr Transpl"},{"key":"R89-20250108","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/ajt.16336","article-title":"Validity and utility of urinary CXCL10\/Cr immune monitoring in pediatric kidney transplant recipients","volume":"21","author":"Blydt-Hansen","year":"2021","journal-title":"Am J Transplant"},{"key":"R90-20250108","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/children10010128","article-title":"Diagnosing acute cellular rejection after paediatric liver transplantation\u2014is there room for interleukin profiles?","volume":"10","author":"Goldschmidt","year":"2023","journal-title":"Children"},{"key":"R91-20250108","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOT.0000000000000959","article-title":"Biomarkers of rejection in liver transplantation","volume":"27","author":"Perottino","year":"2022","journal-title":"Curr Opin Organ Transpl"},{"key":"R92-20250108","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the assessing donor-derived cell-free DNA monitoring insights of kidney allografts with longitudinal surveillance (ADMIRAL) study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"key":"R93-20250108","doi-asserted-by":"crossref","first-page":"E135","DOI":"10.1097\/TP.0000000000003084","article-title":"Performance of donor-derived cell-free DNA assays in kidney transplant patients","volume":"104","author":"Grskovic","year":"2020","journal-title":"Transplantation"},{"key":"R94-20250108","doi-asserted-by":"crossref","first-page":"e0220552","DOI":"10.1371\/journal.pone.0220052","article-title":"A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring","volume":"14","author":"Sigdel","year":"2019","journal-title":"PLoS One"},{"key":"R95-20250108","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41581-021-00428-0","article-title":"Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury","volume":"17","author":"Oellerich","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R96-20250108","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1097\/TXD.0000000000001061","article-title":"Donor-derived cell-free DNA and the prediction of BK virus-associated nephropathy","volume":"6","author":"Kant","year":"2020","journal-title":"Transpl Direct"},{"key":"R97-20250108","doi-asserted-by":"crossref","first-page":"1263389","DOI":"10.3389\/fimmu.2023.1263389","article-title":"Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"R98-20250108","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/TP.0000000000004482","article-title":"Understanding donor-derived cell-free DNA in kidney transplantation: an overview and case-based guide for clinicians","volume":"107","author":"Graver","year":"2023","journal-title":"Transplantation"},{"key":"R99-20250108","doi-asserted-by":"crossref","first-page":"731","DOI":"10.17305\/bb.2024.10049","article-title":"Donor-derived cell-free DNA as a diagnostic marker for kidney-allograft rejection: a systematic review and meta-analysis","volume":"24","author":"Xing","year":"2024","journal-title":"Biomol Biomed"},{"key":"R100-20250108","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study","volume":"19","author":"Oellerich","year":"2019","journal-title":"Am J Transplant."},{"key":"R101-20250108","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/ajt.15289","article-title":"Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients","volume":"19","author":"Huang","year":"2019","journal-title":"Am J Transplant."},{"key":"R102-20250108","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-Free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"R103-20250108","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1097\/TXD.0000000000000821","article-title":"Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients","volume":"4","author":"Jordan","year":"2018","journal-title":"Transpl Direct"},{"key":"R104-20250108","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/tri.13970","article-title":"Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients","volume":"34","author":"Mayer","year":"2021","journal-title":"Transpl Int."},{"key":"R105-20250108","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/TP.0000000000004324","article-title":"Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: results from the trifecta study","volume":"107","author":"Halloran","year":"2023","journal-title":"Transplantation"},{"key":"R106-20250108","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1097\/TP.0000000000004212","article-title":"Combining donor-derived cell-free DNA fraction and quantity to detect kidney transplant rejection using molecular diagnoses and histology as confirmation","volume":"106","author":"Halloran","year":"2022","journal-title":"Transplantation"},{"key":"R107-20250108","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1681\/ASN.2021050645","article-title":"Using both the fraction and quantity of donor-derived cell-free DNA to detect kidney allograft rejection","volume":"32","author":"Bunnapradist","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R108-20250108","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ndt\/gfad120","article-title":"Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function","volume":"39","author":"Cucchiari","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"R109-20250108","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med."},{"key":"R110-20250108","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.3390\/cancers15123165","article-title":"Cell-free DNA as a surveillance tool for hepatocellular carcinoma patients after liver transplant","volume":"15","author":"Manzi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R111-20250108","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MOT.0000000000000924","article-title":"Progress and challenges in diagnosis and treatment of rejec following liver transplanta","volume":"26","author":"Cuervo","year":"2021","journal-title":"Curr Opin Organ Transpl"},{"key":"R112-20250108","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajt.16835","article-title":"Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients","volume":"22","author":"Levitsky","year":"2022","journal-title":"Am J Transplant"},{"key":"R113-20250108","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/lt.26479","article-title":"Elevated fractional donor-derived cell-free DNA during subclinical graft injury after liver transplantation","volume":"28","author":"Baumann","year":"2022","journal-title":"Liver Transplant"},{"key":"R114-20250108","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/hepr.13978","article-title":"Noninvasive graft monitoring using donor-derived cell-free DNA in Japanese liver transplantation","volume":"54","author":"Kanamori","year":"2024","journal-title":"Hepatol Res"},{"key":"R115-20250108","doi-asserted-by":"crossref","first-page":"e1002286","DOI":"10.1371\/journal.pmed.1002286","article-title":"Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: a prospective, observational, multicenter cohort study","volume":"14","author":"Sch\u00fctz","year":"2017","journal-title":"PLoS Med."},{"key":"R116-20250108","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1097\/TXD.0000000000000902","article-title":"The measurement of donor-specific cell-free DNA identifies recipients with biopsy-proven acute rejection requiring treatment after liver transplantation","volume":"5","author":"Goh","year":"2019","journal-title":"Transpl Direct"},{"key":"R117-20250108","doi-asserted-by":"crossref","first-page":"e14708","DOI":"10.1111\/petr.14708","article-title":"Evaluating threshold for donor fraction cell-free DNA using clinically available assay for rejection in pediatric and adult heart transplantation","volume":"28","author":"Deshpande","year":"2024","journal-title":"Pediatr Transpl"},{"key":"R118-20250108","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCULATIONAHA.120.049098","article-title":"Cell-free DNA to detect heart allograft acute rejection","volume":"143","author":"Agbor-Enoh","year":"2021","journal-title":"Circulation"},{"key":"R119-20250108","doi-asserted-by":"crossref","first-page":"11260","DOI":"10.3389\/ti.2023.11260","article-title":"Absolute quantification of donor-derived cell-free DNA in pediatric and adult patients after heart transplantation: a prospective study","volume":"36","author":"B\u00f6hmer","year":"2023","journal-title":"Transpl Int"},{"key":"R120-20250108","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.healun.2022.04.002","article-title":"A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation","volume":"41","author":"Kim","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R121-20250108","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/TP.0000000000003725","article-title":"Graft-derived cell-free DNA as a noninvasive biomarker of cardiac allograft rejection: a cohort study on clinical validity and confounding factors","volume":"106","author":"Kn\u00fcttgen","year":"2022","journal-title":"Transplantation"},{"key":"R122-20250108","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1038\/s41598-021-85949-1","article-title":"Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction","volume":"11","author":"Veraar","year":"2021","journal-title":"Sci Rep"},{"key":"R123-20250108","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"key":"R124-20250108","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.healun.2021.04.009","article-title":"Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study","volume":"40","author":"Jang","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R125-20250108","doi-asserted-by":"crossref","first-page":"10546","DOI":"10.3389\/ti.2022.10546","article-title":"Validation of a simple, rapid, and cost-effective method for acute rejection monitoring in lung transplant recipients","volume":"35","author":"Sorbini","year":"2022","journal-title":"Transpl Int"},{"key":"R126-20250108","doi-asserted-by":"crossref","first-page":"1263389","DOI":"10.3389\/fimmu.2023.1263389","article-title":"Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"R127-20250108","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MOT.0000000000000979","article-title":"Cell-free DNA in lung transplantation: research tool or clinical workhorse?","volume":"27","author":"Keller","year":"2022","journal-title":"Curr Opin Organ Transpl"},{"key":"R128-20250108","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/ajt.17039","article-title":"Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients","volume":"22","author":"Keller","year":"2022","journal-title":"Am J Transplant."},{"key":"R129-20250108","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13665-022-00292-8","article-title":"Why cell-free DNA can be a \u201cgame changer\u201d for lung allograft monitoring for rejection and infection","volume":"11","author":"Rosenheck","year":"2022","journal-title":"Curr Pulmonol Rep."},{"key":"R130-20250108","doi-asserted-by":"crossref","first-page":"E608","DOI":"10.1097\/TXD.0000000000001063","article-title":"Plasma donor-derived cell-free DNA levels are increased during acute cellular rejection after lung transplant: pilot data","volume":"6","author":"Sayah","year":"2020","journal-title":"Transpl Direct"},{"key":"R131-20250108","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1111\/ajt.17125","article-title":"Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunction","volume":"22","author":"Bazemore","year":"2022","journal-title":"Am J Transplant."},{"key":"R132-20250108","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12890-022-02229-y","article-title":"Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients","volume":"23","author":"Ju","year":"2023","journal-title":"BMC Pulm Med."},{"key":"R133-20250108","doi-asserted-by":"crossref","first-page":"E1487","DOI":"10.1097\/TXD.0000000000001487","article-title":"Relative change in donor-derived cell-free DNA is superior to absolute values for diagnosis of acute lung allograft dysfunction","volume":"9","author":"Trindade","year":"2023","journal-title":"Transpl Direct"},{"key":"R134-20250108","doi-asserted-by":"crossref","first-page":"102073","DOI":"10.1016\/j.trim.2024.102073","article-title":"Lung transplantation: current insights and outcomes","volume":"85","author":"Napoli","year":"2024","journal-title":"Transpl Immunol."},{"key":"R135-20250108","doi-asserted-by":"crossref","first-page":"e0227385","DOI":"10.1371\/journal.pone.0227385","article-title":"Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: validation of a rapid and highly sensitive clinical test for stratification of rejection probability","volume":"15","author":"North","year":"2020","journal-title":"PLoS One"},{"key":"R136-20250108","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/clinchem\/hvaa173","article-title":"Cell-free DNA in pediatric solid organ transplantation using a new detection method of separating donor-derived from recipient cell-free DNA","volume":"66","author":"Preka","year":"2020","journal-title":"Clin Chem"},{"key":"R137-20250108","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"R138-20250108","doi-asserted-by":"crossref","first-page":"e14582","DOI":"10.1111\/petr.14582","article-title":"Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: a single center study","volume":"28","author":"Ranch","year":"2024","journal-title":"Pediatr Transpl."},{"key":"R139-20250108","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00467-011-1969-8","article-title":"Surveillance biopsies in children post-kidney transplant","volume":"27","author":"Birk","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R140-20250108","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41598-020-80845-6","article-title":"Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients","volume":"11","author":"Zhao","year":"2021","journal-title":"Sci Rep."},{"key":"R141-20250108","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.3389\/ti.2023.12406","article-title":"Donor-derived cell-free DNA: attractive biomarker seeks a context of use","volume":"36","author":"Pagliazzi","year":"2023","journal-title":"Transpl Int"},{"key":"R142-20250108","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/TP.0000000000003651","article-title":"Donor-derived cell-free DNA in solid-organ transplant diagnostics: indications, limitations, and future directions","volume":"105","author":"Kataria","year":"2021","journal-title":"Transplantation"},{"key":"R143-20250108","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/TP.0000000000003393","article-title":"The monitoring of donor-derived cell-free DNA in kidney transplantation","volume":"105","author":"Filippone","year":"2021","journal-title":"Transplantation"},{"key":"R144-20250108","doi-asserted-by":"crossref","first-page":"e0186827","DOI":"10.1371\/journal.pone.0186827","article-title":"Association between the pancreas transplantation and survival of patients with diabetes: a single center experience","volume":"12","author":"Choi","year":"2017","journal-title":"PLoS One"},{"key":"R145-20250108","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1111\/ajt.15959","article-title":"Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection","volume":"20","author":"Tinel","year":"2020","journal-title":"Am J Transplant"},{"key":"R146-20250108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9082325","article-title":"Clinical and analytical validation of a novel urine-based test for the detection of allograft rejection in renal transplant patients","volume":"9","author":"Nolan","year":"2020","journal-title":"J Clin Med"},{"key":"R147-20250108","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1053\/j.ajkd.2023.07.022","article-title":"Automated urinary chemokine assays for noninvasive detection of kidney transplant rejection: a prospective cohort study","volume":"83","author":"Van Loon","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"R148-20250108","doi-asserted-by":"crossref","first-page":"656632","DOI":"10.3389\/fimmu.2021.656632","article-title":"Non-invasive diagnosis for acute rejection using urinary mRNA signature reflecting allograft status in kidney transplantation","volume":"12","author":"Seo","year":"2021","journal-title":"Front Immunol."},{"key":"R149-20250108","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.3390\/ijms25105139","article-title":"Efficacy of integrated risk score using omics-based biomarkers for the prediction of acute rejection in kidney transplantation: a randomized prospective pilot study","volume":"25","author":"Lim","year":"2024","journal-title":"Int J Mol Sci."},{"key":"R150-20250108","doi-asserted-by":"crossref","first-page":"E711","DOI":"10.1097\/TXD.0000000000001169","article-title":"A combined microRNA and chemokine profile in urine to identify rejection after kidney transplantation","volume":"7","author":"Gielis","year":"2021","journal-title":"Transpl Direct"},{"key":"R151-20250108","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.healun.2024.05.003","article-title":"Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: outcomes from the Surveillance HeartCare Outcomes Registry","volume":"43","author":"Khush","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R152-20250108","doi-asserted-by":"crossref","first-page":"e02025107","DOI":"10.1371\/journal.pone.0205107","article-title":"The common rejection module in chronic rejection post lung transplantation","volume":"13","author":"Sacreas","year":"2018","journal-title":"PLoS One"},{"key":"R153-20250108","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2024.05.032","article-title":"Plasma immune signatures can predict rejection-free survival in the first year after pediatric liver transplantation","volume":"81","author":"Chichelnitskiy","year":"2024","journal-title":"J Hepatol"},{"key":"R154-20250108","doi-asserted-by":"crossref","first-page":"E791","DOI":"10.1097\/TXD.0000000000001244","article-title":"Design and methods of the validating injury to the renal transplant using urinary signatures (VIRTUUS) study in children","volume":"7","author":"Kumar","year":"2021","journal-title":"Transpl Direct"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:01:36Z","timestamp":1736348496000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001276","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"2024-08-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}